News Archives - Page 4 of 12 - The Progeria Research Foundation

Exciting breakthroughs in RNA Therapeutics for Progeria!

Karen Betournay March 11, 2021 No Comments

We’re thrilled to share the results from two very exciting breakthrough studies on the use of RNA therapeutics in Progeria research. Both studies were co-funded by The Progeria Research Foundation…

Kicking off the New Year with exciting research news!

Karen Betournay January 6, 2021 No Comments

In January, the science journal Nature published breakthrough results demonstrating that genetic editing in a mouse model of Progeria corrected the mutation that causes Progeria in many cells, improved several…

The day has come: FDA approval for first-ever Progeria treatment!

Karen Betournay November 20, 2020 No Comments

We’re thrilled to announce that today, we achieved an important piece of PRF’s mission: lonafarnib, the first-ever treatment for Progeria, has been granted FDA approval.

PRF’s 10th International Scientific Workshop

Karen Betournay November 2, 2020 No Comments

Enjoy some clips, photos, comments, and Q&A!

PRF’s 2020 Newsletter!

Karen Betournay October 3, 2020 No Comments

Read about how our progress continues despite the pandemic; the science driving PRF’s latest grant recipients to propel Progeria research to new heights; inspiring thoughts from families in our Progeria…

July 20: PRF’s Annual ONEpossible Campaign a Success!

Karen Betournay May 30, 2020 No Comments

From all of us at PRF, as well as the children and their families, THANK YOU to everyone who donated to our ONEpossible campaign!! We CRUSHED our goal – which…

A Note to our PRF Community

Karen Betournay April 1, 2020 No Comments

First and foremost, we hope you are staying well. In light of the recent progression of COVID-19, and as we all navigate this uncertain time, we want to THANK YOU…

Application to FDA for lonafarnib approval is COMPLETE!

Karen Betournay March 23, 2020 No Comments

During an otherwise difficult time for our world, we are happy to share a bright spot: Eiger BioPharmaceuticals has completed submission of a New Drug Application (NDA), seeking approval -…

Submission of application to FDA for lonafarnib approval has begun!

Karen Betournay December 18, 2019 No Comments

We’re thrilled to announce a milestone in our mission to treat and cure children with Progeria: In partnership with The Progeria Research Foundation, Eiger BioPharmaceuticals has submitted to the FDA…

PRF’s 2019 Newsletter

Karen Betournay September 30, 2019 No Comments

Get exciting updates on our progress over the past year, learn why we now refer to the population we serve as children – and young adults – with Progeria, check…

Category: News